← Back to Clinical Trials
Recruiting NCT07103993

NCT07103993 Food Intake and Thermogenesis in High Spinal Cord Injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07103993
Status Recruiting
Phase
Sponsor University of Miami
Condition SCI - Spinal Cord Injury
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2026-03-13
Primary Completion 2027-12-31

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Low meal conditionModerate meal conditionHigh meal condition

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 56 participants in total. It began in 2026-03-13 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research is to determine the effects of food on cardiovascular and metabolic health in men with and without spinal cord injury (SCI).

Eligibility Criteria

Inclusion Criteria: SCI and Controls * Men * Physically inactive (\<150 minutes per week of moderate-vigorous activity intensity for the preceding 3 months) * Weight stable: body mass ±3 kilograms (kg) for past 3 months SCI Only * Chronic SCI (≥ 1-year post-injury) * Motor-complete SCI American Spinal Injury Association Impairment Scale (AIS) A and B * T6 injuries and above that can independently feed themselves Exclusion Criteria: SCI and Controls * Uncompensated thyroid disease * Diabetes * Swallowing or gastrointestinal pathologies * Allergies or aversions to foods/ingredients * Prescribed prokinetic, antipsychotic, or anti-obesity agents SCI Only * Incomplete SCI AIS C or D * Ventilator-dependent

Contact & Investigator

Central Contact

Guillermo Mederos

✉ gxm1228@med.miami.edu

📞 (305) 243-4518

Principal Investigator

Gary J Farkas, PhD

PRINCIPAL INVESTIGATOR

University of Miami

Frequently Asked Questions

Who can join the NCT07103993 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 65 Years, studying SCI - Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07103993 currently recruiting?

Yes, NCT07103993 is actively recruiting participants. Contact the research team at gxm1228@med.miami.edu for enrollment information.

Where is the NCT07103993 trial being conducted?

This trial is being conducted at Miami, United States.

Who is sponsoring the NCT07103993 clinical trial?

NCT07103993 is sponsored by University of Miami. The principal investigator is Gary J Farkas, PhD at University of Miami. The trial plans to enroll 56 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology